glp-1 drugs metformin What next after metformin? A GPnotebook Shortcut Semaglutide dominates GLP-1 receptor agonist

If we have to choose the credit for the early GLP-1 drug discovery and research, let us trace the history of GLP-1 drug discovery

Unpublished results from the first phase II trial with the triple combination of semaglutide, cilofexor and/or firsocostat treatment for 24 weeks in 108 patients with NASH showed significant improvements in hepatic steatosis (measured with MRI) and liver injury (measured by serum alanine aminotransferase) in the combination treatment arm vs semaglutide monotherapy (56)

Semaglutide 2.4 mg for managing overweight and obesity (TA875)

Dermal hypersensitivity reaction to semaglutide: two case reports

[DOI] [PubMed] [Google Scholar] 28.Exton JH, Park CR

The growth in the historic period can be attributed to rising prevalence of type 2 diabetes, increased awareness of glycemic control therapies, strong clinical efficacy versus traditional antidiabetics, physician preference for incretin-based therapies, favorable reimbursement in developed markets